ASX Announcements
Sort by
Quarterly Activities/Appendix 4C Cash Flow Report
Amplia Receives R&D Tax Rebate Totalling $4.78 Million
Amplia Therapeutics Provides Clinical Trial Updates
Response to ASX Price Query
Amplia Presents at CG Drug and Device Conference 2026
Amplia Presents at E&P Healthcare Conference 2026
Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial
Notification regarding unquoted securities - ATX
Results of Annual General Meeting
CEO Managing Director Presentation to Annual General Meeting
| Date | Headline |
|---|---|
28 Oct 2026 | Quarterly Activities/Appendix 4C Cash Flow Report |
22 Oct 2026 | Amplia Receives R&D Tax Rebate Totalling $4.78 Million |
22 Oct 2026 | Amplia Therapeutics Provides Clinical Trial Updates |
16 Oct 2026 | Response to ASX Price Query |
13 Oct 2026 | Amplia Presents at CG Drug and Device Conference 2026 |
16 Sep 2026 | Amplia Presents at E&P Healthcare Conference 2026 |
15 Sep 2026 | Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial |
9 Sep 2026 | Notification regarding unquoted securities - ATX |
28 Aug 2026 | Results of Annual General Meeting |
28 Aug 2026 | CEO Managing Director Presentation to Annual General Meeting |